Company intelligence / Profile preview

Beacon of Hope CRO

Delray Beach, Florida, United States

Ownership: Private
Development stage: Other

Overview

Beacon of Hope CRO was a U.S.-based contract research organization focused on helping biotech and pharmaceutical companies provide patients with safe, ethical, and legal access to investigational treatments outside traditional clinical trials. The company positioned itself as a Right to Try and expanded-access focused CRO, offering infrastructure around research-site operations and patient recruitment for seriously ill patients. It launched in 2019 and later announced a name change to Access Hope CRO. Available company-profile and corporate-registration sources indicate the business is no longer active.

Therapeutic areas: Rare Diseases
Industry: Contract Research Organization

Beyond the preview

Go deeper on Beacon of Hope CRO.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beacon of Hope CRO.

Explore the full profile